VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 137 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $42,000 | -49.4% | 2,557 | -57.1% | 0.04% | -43.5% |
| Q1 2017 | $83,000 | -77.1% | 5,957 | -73.7% | 0.07% | -53.7% |
| Q4 2016 | $362,000 | +119.4% | 22,687 | +129.3% | 0.15% | +35.5% |
| Q3 2016 | $165,000 | +75.5% | 9,894 | +18.1% | 0.11% | +57.1% |
| Q2 2016 | $94,000 | -7.8% | 8,378 | -31.3% | 0.07% | -1.4% |
| Q1 2016 | $102,000 | – | 12,200 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |